Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:clonazepam
|
| gptkbp:approvalYear |
1975
|
| gptkbp:ATCCode |
N03AE01
|
| gptkbp:brand |
gptkb:clonazepam
|
| gptkbp:contraindication |
acute narrow-angle glaucoma
severe liver disease |
| gptkbp:controlledSubstanceSchedule |
Schedule IV (US)
|
| gptkbp:countryOfOperation |
gptkb:Brazil
gptkb:Portugal gptkb:Switzerland |
| gptkbp:drugClass |
benzodiazepine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rivotril
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Roche
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:riskFactor |
dependence
withdrawal symptoms |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
dizziness
fatigue drowsiness impaired coordination |
| gptkbp:usedFor |
gptkb:panic_disorder
epilepsy anxiety disorders |
| gptkbp:bfsParent |
gptkb:Clonazepam
gptkb:clonazepam |
| gptkbp:bfsLayer |
7
|